A study of admissions data from more than 136,000 patients over eight years showed that . Researchers suggested that hospitals could create specialized discharge planning for patients who test positive for methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci or Clostridium difficile.
Hospitals with the best heart attack survival rates have strong doctor-nurse teamwork, monthly meetings between hospital clinicians and paramedics, and a pharmacist on the daily care team. Yale researchers also found that fewer than 10 percent of hospitals nationwide use these strategies in their study of deaths after heart attacks in 537 hospitals from January 2008 to December 2009.
A congressman from New York has proposed a bill that creates financial penalties for pharma companies who fail to post clinical trial results at clinicaltrials.gov. Pharmalot reports that the bill would also withhold federal grant funding to any organization that does not report results – and require repayment. Read the bill here.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Another bill currently being considered by Congress would provide antibiotic developers an additional five years of market exclusivity for their products. Generating Antibiotic Incentives Now might be enough to draw big companies, small companies, and venture investors into antibiotic development.
Better charge capture and the ability to access data from anywhere are two of the main advantages of electronic health records. No guarantee of increased productivity and multiple steps for data entry are two of the big drawbacks that doctors identified in a Beckers Hospital Review post about pros and cons of EHRs.
[Image from flicker user Nathan Reading]
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
